A new personalised skin cancer vaccine has been found to reduce the risk of patients dying or their cancer returning by 42%. As part of a global two-year clinical trial, more than 1,000 patients who had already had their tumours removed were given a widely used immunotherapy drug. Around two-thirds were then given the experimental vaccine, which was developed using cells from their own tumours. Researchers say the results could mark a turning point in cancer treatment.
Also: How a man achieved his goal of becoming a world-famous singer without even knowing it. The neighbours who rallied together to fulfil an autistic boy's dream. The "brain bank" giving hope to Parkinson's patients. A ballet school offering a brighter future for children living in one of the poorest parts of the world. And how one conservationist's determination helped save the threatened African manatee.
Our weekly collection of inspiring, uplifting and happy news from around the world.
(Photo: A man receives a personalised vaccine as part of a global cancer treatment trial. Credit: Addenbrooke's Hospital)
